Discover how Trump’s healthcare picks could reshape U.S. biopharma and drive major changes in the healthcare policy.

Discover various promising treatments in development to address the unmet needs of people with Charcot–Marie–Tooth disease.

Learn more about six antisense oligonucleotide companies shaping the future of genetic medicine, just as the market is ...

Delve into the field of miRNA with 7 promising companies with miRNA-focused candidates in the pipeline, from oncology to ...

As the signs point toward a potential Evotec acquisition, delve into what it could represent for the European biotech ...

Discover how ADCs are advancing oncology, the regulatory challenges they face, and the promise they hold for the future of ...